Showing 21-30 of 749 results for "".
Treating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.The “Aged Microenvironment”: New Understandings of Melanoma Spread and Aggression
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-aged-microenvironment-new-understandings-of-melanoma-spread-and-aggression/20863/New research sheds light on pathways through which melanoma may become more aggressive.Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.The Evidence for Slow- and Fast-growing Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/1109_06-php/22058/Recent findings support the existence of slow-growing melanomas, offering a possible explanation for anomalies in melanoma incidence reporting.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Risk Factor: Characterizing Melanoma Risk Clinically
https://practicaldermatology.com/topics/practice-management/risk-factor-characterizing-melanoma-risk-clinically/20844/Can clinical features help determine an individual's melanoma risk?Viagra and Aggressive Melanoma: Is There a Link?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/viagra-and-aggressive-melanoma-is-there-a-link/20998/New findings offer insight into the possible effects of the popular prescription on melanoma growth.MelaFind in Practice: Real-Time Insights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melafind-in-practice-real-time-insights/22969/MelaFind helps dermatologists to be more accurate, but it also serves the dual function of preventing unnecessary biopsies.FDA Approves New Melanoma Treatment with Novel MOA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dwtv-9-11-14--iloojede/19075/Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalled.Is it Really Melasma?
https://practicaldermatology.com/conferences/aad-2023/is-it-really-melasma/20174/Melasma is one of the most common hyperpigmentation disorders, especially in patients with darker skin tones, but it’s not always a slam-dunk diagnosis. It’s important to consider less common disorders of pigmentation on the face such as lichen planus pigmentosus, shares Andrew Alexis, MD. He also